Wassil Jim, COO, reported an open-market or private sale at Vaxcyte, Inc. involving 1562.000000 shares for an estimated $100425.67. Reported holdings after the transaction were 176045.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
Chief Operating Officer
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2023.
The price reported is a weighted-average price. The shares were sold at prices ranging from $62.01 to $62.94. The reporting person will provide upon request to the SEC, the issuer or security holder o…
The price reported is a weighted-average price. The shares were sold at prices ranging from $63.13 to $63.885. The reporting person will provide upon request to the SEC, the issuer or security holder…
The price reported is a weighted-average price. The shares were sold at prices ranging from $64.13 to $64.99. The reporting person will provide upon request to the SEC, the issuer or security holder o…
1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter.
0 other filings
0 recent txs